Search hospitals > Illinois > Pekin
Illinois CancerCare-Pekin
Claim this profilePekin, Illinois 61554
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
478 reported clinical trials
2 medical researchers
Summary
Illinois CancerCare-Pekin is a medical facility located in Pekin, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Illinois CancerCare-Pekin is involved with conducting 478 clinical trials across 492 conditions. There are 2 research doctors associated with this hospital, such as Bryan A. Faller and James L. Wade.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Bryan A. FallerCrossroads Cancer Center2 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
226 reported clinical trials
291 drugs studied
James L. WadeDecatur Memorial Hospital3 years of reported clinical research
Studies Recurrence
Studies Breast Cancer
11 reported clinical trials
20 drugs studied
Clinical Trials running at Illinois CancerCare-Pekin
Breast Cancer
Prostate Cancer
Cancer
Gastric Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Cancer
Pancreatic Cancer
Squamous Cell Carcinoma
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Illinois CancerCare-Pekin?
Illinois CancerCare-Pekin is a medical facility located in Pekin, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Illinois CancerCare-Pekin is involved with conducting 478 clinical trials across 492 conditions. There are 2 research doctors associated with this hospital, such as Bryan A. Faller and James L. Wade.
Where is Illinois CancerCare-Pekin located?
Illinois CancerCare-Pekin is located at 1641 Broadway Street, Pekin, IL 61554. This hospital is currently accepting new patients and provides a range of cancer treatments.
Who should I call to ask about financial aid or insurance network?
**Illinois CancerCare-Pekin Contact Information:**
- **Financial Assistance:** Reach out to the Patient Financial Counselor for assistance with insurance benefits, foundation applications, grants, and managing out-of-pocket expenses. Contact at (309) 243-3500 or toll-free (866) 662-6564.
- **Insurance and Billing Inquiries:** Contact the Illinois CancerCare Business Office for insurance claims, pre-certifications, and understanding insurance coverage and financial responsibilities. Call (309) 243-3500 or toll-free (866) 662-6564.
- **General Inquiries:** For any other questions, call the Illinois CancerCare-Pekin location at (309) 243-3500.
What insurance does Illinois CancerCare-Pekin accept?
Illinois CancerCare-Pekin accepts a wide range of insurance plans, including but not limited to Medicare, Aetna (HMO, PPO, POS), BCBS of Illinois (PPO, POS, EPO, Classic Blue HMO, HMOI, Blue Advantage HMO), Beech Street PPO, Cigna/Great West Healthcare (HMO, PPO, POS, Open Access), and United Health Care. Other accepted insurances include Coventry/First Health/Personal Care, Humana (HMO, PPO, Choice POS, Choice Care Network), and Multiplan. Patients are advised to verify physician participation in their plan and discuss any necessary pre-certification with the office.
What awards or recognition has Illinois CancerCare-Pekin received?
Illinois CancerCare-Pekin, located in Pekin, Illinois, is distinguished by the Quality Oncology Practice Initiative (QOPI®) Certification Program for its outstanding outpatient hematology-oncology practices. It was honored in 2015 by the Alliance for Clinical Trials in Oncology as a leading institution in clinical research enrollment. Additionally, it received the 2007 Clinical Trials Participation Award from the American Society of Clinical Oncology for its significant contributions to advancing cancer treatments through clinical trials.